iCanCope With Sickle Cell Pain

NCT03201874 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2023-12-13

Study results available
· View outcomes & findings →

Summary

The project will test a tailored web and smartphone-based application (iCanCope with SCD) to improve pain self-management and functioning in youth (aged 12-18) with sickle cell disease. The program will include goal setting, peer-based social support, and pain self-management training. The investigators will determine initial program effectiveness through a pilot three-site randomized controlled trial in 160 youth randomized to treatment compared to attention control.

Conditions

Interventions

BEHAVIORAL

Pain self-management

The program is designed to enhance self-efficacy. The app will guide youth in setting structured and personalized goals aimed at improving their pain and functioning. The pain self-management skills will include personalized CBT-based coping skills including deep breathing, relaxation, and cognitive skills (e.g., staying positive). The app will provide in-the-moment access to pain coping strategies to promote positive changes in mood, behavior, and pain.

BEHAVIORAL

Education

Education about sickle cell disease to increase disease knowledge

Sponsors & Collaborators

  • The Hospital for Sick Children

    collaborator OTHER
  • Emory University

    collaborator OTHER
  • Connecticut Children's Medical Center

    collaborator OTHER
  • University of Mississippi Medical Center

    collaborator OTHER
  • University of Florida

    collaborator OTHER
  • Boston Medical Center

    collaborator OTHER
  • Northwestern University

    collaborator OTHER
  • Seattle Children's Hospital

    lead OTHER

Principal Investigators

  • Tonya M Palermo, PhD · Seattle Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03201874 on ClinicalTrials.gov